Ischemic stroke market Research Report-  Forecast till 2030

Ischemic Stroke Market research report: by diagnosis (CT, MRI, carotid ultrasound, cerebral angiography), drug class (tissue plasminogen activator, anticoagulant, antiplatelet, antihypertensive), surgery, end user – forecast till 2030

ID: MRFR/MED/3980-HCR | February 2021 | Region: Global | 120 Pages         

TABLE OF CONTENT


Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Surgery Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 7. Global Ischemic Stroke Market, By Diagnosis

7.1 Introduction

7.2 Computed Tomography (CT)

7.3.1 Market Estimates & Forecast, 2020 – 2027

7.3 Magnetic Resonance Imaging (MRI)

7.3.1 Market Estimates & Forecast, 2020 – 2027

7.4 Carotid Ultrasound

7.4.1 Market Estimates & Forecast, 2020 – 2027

7.5 Cerebral Angiography

7.5.1 Market Estimates & Forecast, 2020 – 2027

7.6 Electrocardiography

7.7.1 Market Estimates & Forecast, 2020 – 2027

7.8 Echocardiography

7.8.1 Market Estimates & Forecast, 2020 – 2027

7.4 Others

Chapter 8. Global Ischemic Stroke Market, By Drug Class

8.1 Introduction

8.2 Tissue Plasminogen Activator

8.2.1 Market Estimates & Forecast, 2020 – 2027

8.3 Anticoagulant

8.3.1 Market Estimates & Forecast, 2020 – 2027

8.4 Antiplatelet

8.4.1 Market Estimates & Forecast, 2020 – 2027

8.5 Antihypertensive

8.5.1 Market Estimates & Forecast, 2020 – 2027

8.6 Others

Chapter 9. Global Ischemic Stroke Market, By Surgery

9.1 Introduction

9.2 Carotid Endarterectomy

9.2.1 Market Estimates & Forecast, 2020 – 2027

9.3 Angioplasty

9.3.1 Market Estimates & Forecast, 2020 – 2027

9.4 Endovascular Mechanical Thrombectomy

9.4.1 Market Estimates & Forecast, 2020 – 2027

Chapter 10. Global Ischemic Stroke Market, By End User

10.1 Introduction

10.2 Hospitals & Clinics

10.2.1 Market Estimates & Forecast, 2020 – 2027

10.3 Medical Institutes

10.3.1 Market Estimates & Forecast, 2020 – 2027

10.4 Research Organization

10.4.1 Market Estimates & Forecast, 2020 – 2027

10.5 Others

10.5.1 Market Estimates & Forecast, 2020 – 2027

Chapter. 11 Global Ischemic Stroke Market, By Region

11.1 Introduction

11.2 Americas

11.2.1 North America

11.2.1.1 U.S.

11.2.1.2 Canada

11.2.2 South America

11.3 Europe

11.3.1 Western Europe

11.3.1.1 Germany

11.3.1.2 France

11.3.1.3 Italy

11.3.1.4 Spain

11.3.1.5 U.K

11.3.1.6 Rest Of Western Europe

11.3.2 Eastern Europe

11.4 Asia Pacific

11.4.1 Japan

11.4.2 China

11.4.3 India

11.4.4 Australia

11.4.5 Republic Of Korea

11.4.6 Rest Of Asia Pacific

11.5 The Middle East & Africa

11.5.1 United Arab Emirates

11.5.2 Saudi Arabia

11.5.3 Rest Of The Middle East & Africa

Chapter 12 Company Landscape

12.1 Introduction

12.2 Market Share Analysis

12.3 Key Development & Strategies

12.3.1 Key Developments

Chapter 13 Company Profiles

13.1 Abbott Laboratories

13.1.1 Company Overview

13.1.2 Drug Class Overview

13.1.3 Financials

13.1.4 SWOT Analysis

13.2 Medtronic Plc

13.2.1 Company Overview

13.2.2 Drug Class Overview

13.2.3 Financial Overview

13.2.4 Key Developments

13.2.5 SWOT Analysis

13.3 Boston Scientific Corporation

13.3.1 Company Overview

13.3.2 Drug Class Overview

13.3.3 Financial Overview

13.3.4 Key Development

13.3.5 SWOT Analysis

13.4 Cordis Corporation

13.4.1 Company Overview

13.4.2 Drug Class/Business Segment Overview

13.4.3 Financial Overview

13.4.4 Key Development

13.4.5 SWOT Analysis

13.5 Merck & Co., Inc.

13.5.1 Company Overview

13.5.2 Drug Class Overview

13.5.3 Financial Overview

13.5.4 Key Developments

13.6 Koninklijke Philips N.V.

13.6.1 Company Overview

13.6.2 Drug Class Overview

13.6.3 Financial Overview

13.6.4 Key Developments

13.7 GE Healthcare

13.7.1 Overview

13.7.2 Drug Class Overview

13.7.3 Financials

13.7.4 Key Developments

13.7.5 SWOT Analysis

13.8 Stryker Corporation

13.8.1 Company Overview

13.8.2 Drug Class/Business Segment Overview

13.8.3 Financial Overview

13.8.4 Key Development

13.8.5 SWOT Analysis

13.9 Pfizer Inc.

13.9.1 Company Overview

13.9.2 Drug Class Overview

13.9.3 Financial Overview

13.9.4 Key Developments

13.10 Others

Chapter 14 MRFR Conclusion

14.1 Key Findings

14.1.1 From CEO’s View Point

14.1.2 Unmet Needs Of The Market

14.2 Key Companies To Watch

14.3 Prediction Of Pharmaceutical Industry

Chapter 15 Appendix


LIST OF TABLES


Table 1 Ischemic Stroke Industry Synopsis, 2020 – 2027

Table 2 Ischemic Stroke Market Estimates And Forecast, 2020 – 2027, (USD Million)

Table 3 Ischemic Stroke Market By Region, 2020 – 2027, (USD Million)

Table 4 Ischemic Stroke Market By Diagnosis, 2020 – 2027, (USD Million)

Table 5 Ischemic Stroke Market By Drug Class, 2020 – 2027, (USD Million)

Table 6 Ischemic Stroke Market By Surgery, 2020 – 2027, (USD Million)

Table 7 Ischemic Stroke Market By End Users, 2020 – 2027, (USD Million)

Table 8 North America Ischemic Stroke Market By Diagnosis, 2020 – 2027, (USD Million)

Table 9 North America Ischemic Stroke Market By Drug Class, 2020 – 2027, (USD Million)

Table 10 North America Ischemic Stroke Market By Surgery, 2020 – 2027, (USD Million)

Table 11 North America Ischemic Stroke Market By End User, 2020 – 2027, (USD Million)

Table 12 US Ischemic Stroke Market By Diagnosis, 2020 – 2027, (USD Million)

Table 13 US Ischemic Stroke Market By Drug Class, 2020 – 2027, (USD Million)

Table 14 US Ischemic Stroke Market By Surgery, 2020 – 2027, (USD Million)

Table 15 US Ischemic Stroke Market By End User, 2020 – 2027, (USD Million)

Table 16 Canada Ischemic Stroke Market By Diagnosis, 2020 – 2027, (USD Million)

Table 17 Canada Ischemic Stroke Market By Drug Class, 2020 – 2027, (USD Million)

Table 18 Canada Ischemic Stroke Market By Surgery, 2020 – 2027, (USD Million)

Table 19 Canada Ischemic Stroke Market By End User, 2020 – 2027, (USD Million)

Table 20 South America Ischemic Stroke Market By Diagnosis, 2020 – 2027, (USD Million)

Table 21 South America Ischemic Stroke Market By Drug Class, 2020 – 2027, (USD Million)

Table 22 South America Ischemic Stroke Market By Surgery, 2020 – 2027, (USD Million)

Table 23 South America Ischemic Stroke Market By End User, 2020 – 2027, (USD Million)

Table 24 Europe Ischemic Stroke Market By Diagnosis, 2020 – 2027, (USD Million)

Table 25 Europe Ischemic Stroke Market By Drug Class, 2020 – 2027, (USD Million)

Table 26 Europe Ischemic Stroke Market By Surgery, 2020 – 2027, (USD Million)

Table 27 Europe Ischemic Stroke Market By End User, 2020 – 2027, (USD Million)

Table 28 Western Europe Ischemic Stroke Market By Diagnosis, 2020 – 2027, (USD Million)

Table 29 Western Europe Ischemic Stroke Market By Drug Class, 2020 – 2027, (USD Million)

Table 30 Western Europe Ischemic Stroke Market By Surgery, 2020 – 2027, (USD Million)

Table 31 Western Europe Ischemic Stroke Market By End User, 2020 – 2027, (USD Million)

Table 32 Eastern Europe Ischemic Stroke Market By Diagnosis, 2020 – 2027, (USD Million)

Table 33 Eastern Europe Ischemic Stroke Market By Drug Class, 2020 – 2027, (USD Million)

Table 34 Eastern Europe Ischemic Stroke Market By Surgery, 2020 – 2027, (USD Million)

Table 35 Eastern Europe Ischemic Stroke Market By End User, 2020 – 2027, (USD Million)

Table 36 Asia Pacific Ischemic Stroke Market By Diagnosis, 2020 – 2027, (USD Million)

Table 37 Asia Pacific Ischemic Stroke Market By Drug Class, 2020 – 2027, (USD Million)

Table 38 Asia Pacific Ischemic Stroke Market By Surgery, 2020 – 2027, (USD Million)

Table 39 Asia Pacific Ischemic Stroke Market By End User, 2020 – 2027, (USD Million)

Table 40 The Middle East & Africa Ischemic Stroke Market By Diagnosis, 2020 – 2027, (USD Million)

Table 41 The Middle East & Africa Ischemic Stroke Market By Drug Class, 2020 – 2027, (USD Million)

Table 42 The Middle East & Africa Ischemic Stroke Market By Surgery, 2020 – 2027, (USD Million)

Table 43 The Middle East & Africa Ischemic Stroke Market By End User, 2020 – 2027, (USD Million)



LIST OF FIGURES


Figure 1 Research Process

Figure 2 Segmentation For Ischemic Stroke Market

Figure 3 Segmentation Market Dynamics For Ischemic Stroke Market

Figure 4 Global Ischemic Stroke Market Share, By Diagnosis 2020

Figure 6 Global Ischemic Stroke Market Share, By Drug Class 2020

Figure 7 Global Ischemic Stroke Market Share, By Surgery, 2020

Figure 8 Global Ischemic Stroke Market Share, By End Users, 2020

Figure 9 Global Ischemic Stroke Market Share, By Region, 2020

Figure 10 North America Ischemic Stroke Market Share, By Country, 2020

Figure 11 Europe Ischemic Stroke Market Share, By Country, 2020

Figure 12 Asia Pacific Ischemic Stroke Market Share, By Country, 2020

Figure 13 The Middle East & Africa Ischemic Stroke Market Share, By Country, 2020

Figure 14 Global Ischemic Stroke Market: Company Share Analysis, 2020 (%)

Figure 15 Abbott Laboratories: Key Financials

Figure 16 Abbott Laboratories: Segmental Revenue

Figure 17 Abbott Laboratories: Geographical Revenue

Figure 18 Medtronic Plc: Key Financials

Figure 19 Medtronic Plc: Segmental Revenue

Figure 20 Medtronic Plc: Geographical Revenue

Figure 21 Boston Scientific Corporation: Key Financials

Figure 22 Boston Scientific Corporation: Segmental Revenue

Figure 23 Boston Scientific Corporation: Geographical Revenue

Figure 24 Cordis Corporation: Key Financials

Figure 25 Cordis Corporation: Segmental Revenue

Figure 26 Cordis Corporation: Geographical Revenue

Figure 27 Merck & Co., Inc.: Key Financials

Figure 28 Merck & Co., Inc.: Segmental Revenue

Figure 29 Merck & Co., Inc.: Geographical Revenue

Figure 30 Koninklijke Philips N.V.: Key Financials

Figure 31 Koninklijke Philips N.V.: Segmental Revenue

Figure 32 Koninklijke Philips N.V.: Geographical Revenue

Figure 33 GE Healthcare: Key Financials

Figure 34 GE Healthcare: Segmental Revenue

Figure 35 GE Healthcare: Geographical Revenue

Figure 36 Stryker Corporation: Key Financials

Figure 37 Stryker Corporation: Segmental Revenue

Figure 38 Stryker Corporation: Geographical Revenue

Figure 39 Pfizer Inc.: Key Financials

Figure 40 Pfizer Inc.: Segmental Revenue

Figure 41 Pfizer Inc.: Geographical Revenue

Bottom of Form

Ischemic Stroke Market

The Ischemic Stroke Market size was valued at $31,702.20 million and market has been expected to grow at a CAGR of 7.8% over the estimated forecast period of 2021-2030.

Segmentation

By Diagnosis Ct Mri Carotid Ultrasound Cerebral Angiography
By Drug Class Tissue Plasminogen Activator Anticoagulant Antiplatelet Antihypertensive

Key Players

  • Fujifilm Holdings Corporation
  • Samsung Electronics Co. Ltd
  • Ge Healthcare
  • Siemens Healthcare
  • Kohden Corporation
  • Koninklijke Philips NV

Drivers

  • The raising of global health awareness
Speak to Analyst Request a Free Sample

Ischemic Stroke Market Overview:


According to the industry's latest report, the worldwide Ischemic Stroke market has been expected to grow at a CAGR of 7.8% over the estimated forecast period of 2021-2030.


Strokes generally happen while the blood vessel in the brain breaks and bleeding comes out, or it may happen while there is some block in the blood supply to the brain. Due to this fracture or any kind of blockage, the blood and the oxygen couldn't reach inside the brain tissues. There are normally three types of strokes that are a common disease for every individual worldwide, such as a transient ischemic attack, hemorrhagic stroke, and ischemic stroke. Common diagnosis procedures are included in this method, such as blood tests, magnetic resonance imaging, ultrasound, computerized tomography scan, cerebral angiogram and echocardiograms. All the treatments for this disease are included in aspirin, other antiplatelets and anticoagulants.


The raising of health awareness, rise in the incidence of diabetes, the surge in the number of tobacco users and the growth in the geriatric population helps to drive the ischemic stroke market. However, the new emerging technologies for the diagnosis & treatment procedures for ischemic stroke also help to contribute to the ischemic stroke market growth. The ischemic stroke normally occurs due to the sudden cessation of the maximum amount of blood reaching sections in the brain. The ischemic strokes can be divided into territory affected and mechanism. All the clots inside the body are either thrombotic or embolic, which depends on the development within the body parts. A thrombotic stroke is a common of two, which happens while a clot formation occurs within an artery of the brain. Embolic stroke also occurs while the clot or some kind of small piece of plaque that is fatty deposit breaks from anywhere in the body like in the heart and travels through the bloodstream system that only becomes stuck like a narrow vessel inside the brain. All the symptoms completely depend on the severity of the stroke and the specific location in the brain. Some individuals didn't experience any symptoms. All the symptoms of ischemic stroke include paralysis of one side of the body, changes in alertness, not getting the perfect experience of smells, hearing and taste, swallowing problems, loss of balance of the body, and sometimes it might affect the eye-sight.


COVID-19 Analysis:


According to the Ischemic Stroke market analysis, this disease is caused by the virus, which is called the severity of acute respiratory syndrome of coronavirus 2, which is transmitted within human beings. In addition, due to the outbreak of COVID-19, there is some reduction of hospital sectors. It was due to the fact that people are getting feared about the infection during the period of distancing and the lockdown situation. Several governments implemented a strict lockdown in their region for health emergencies. The international commercial activities and trade sectors have been stopped for a few periods. During the lockdown, the demands for advanced medical devices have been increased so far.


The impact of the COVID-19 has directly affected the global hospital and medical sectors. The overall impact of the disease on the ischemic stroke market value was recorded to be very fairly negative. Due to the decrease in production and manufacturing work, investors have faced a huge loss. Furthermore, the prominent players in this industry have bound to reduce the investment in raw materials and resources due to several hospital-based treatments for ischemic stroke patients. Furthermore, it is one of the most important factors to overcome from this challenging period. Because this global pandemic has been strongly affected by every global industry, most manufacturers want to meet the demands of several sectors.


The Chief Factors Existing in the Market:



  • Key Market Drivers:


Due to the raising of global health awareness just after the lockdown from the epidemic, most of the Ischemic Stroke market key drivers want to fix and set their production work to overcome the challenge of global demands.



  • Market Challenges:


The major challenge for every company is how to meet and overcome the situation from the global pandemic. Most of the investors have been facing a huge loss during this pandemic. Due to the lockdown, the entire ischemic stroke market size has been crashed, and every manufacturer wants to take off their business sectors.



  • Market opportunities:


After the lockdown, the global market has been introduced lots of new market players who contributed to developing and producing a large number of productions. Most of the key factor is that the competition between the markets has been raised significantly due to this.



  • Market Restraints:


During the lockdown, the ischemic stroke market cost has been significantly growing, for which most of the manufacturing products and the cost of the raw materials have significantly improved. To overcome such restraints, most key market players are performing to modernize their factories and production work.


Cumulative Evaluation of the Market:


Raising awareness of global health is essential, especially after decreasing infection of the global pandemic. Many people have become so aware of health consciousness. But still, some kinds of other diseases that can easily affect the body. But the growth of the hospital and modern medical devices have raised this ischemic stroke market tremendously. Due to this, investors also give the chances to the new generation and the new market players who want to set their business in the market. According to this, the new Ischemic Stroke market players can perform a huge number of productions, especially to meet the present global demand. Just after the lockdown, the international commercial business also went on, and due to the trade partnerships and raising of several industrial facilities, most of the advanced medical equipment and medicine cures are coming out in this global market which will be helpful for the patient.


Market Segmentation:


The Ischemic Stroke market has been segmented into five sections: diagnosis, drug class, surgery, end-users, and geographical. The market has been classified into seven platforms in terms of the diagnosis section: computed tomography, magnetic resonance imaging, carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and others. The basis of drug class is further classified into five sections: tissue plasminogen activator, anticoagulant, antiplatelet, antihypertensive, and others. The surgery section is further segmented into three parts: carotid endarterectomy, angioplasty, and endovascular mechanical thrombectomy. In terms of the end-user section, the Ischemic Stroke market is classified into four segments: hospitals & clinics, medical institutes, research organizations, and others. According to the basis of the regional or geographical section, the global market has been classified into five different regions such as Asia-Pacific, Europe, North America, South America and Middle East & Africa.


Regional Analysis:


Due to the favorable government initiatives, technological innovations and the rising demand for ischemic stroke products, North America has been expected to hold the Ischemic Stroke market during the upcoming years. Moreover, most of the prominent market players are now willing to focus on the increase of production work. Due to this, the global market has been expected to increase so far in the upcoming future. In this modern world, several numbers of emerging technology and modern medical equipment have come up around this world for which the procedures of medical workers have been so easy now. Due to the advanced technology and research facilities, there are a lot of chances that generate to invent new cures and medicines.


Due to this, most European regions are willing to establish a maximum number of medical facilities that can easily drive the growth of global market sectors. Furthermore, most of the investors want to invest their funds in the manufacturing industries to grow the production work.


Competitive Intensity within the Industry:


The leading market players of the Ischemic Stroke market have always been looking for an increasing manufacturing rate for global customers. Due to this, the level of competition has been found in the market. The incoming of new faces in this business sector has given an opportunity for several companies to stand out in this market sector. As the global stocks have improved, the share values have also grown significantly. According to this, the investors also want to give a chance to some of the market's new players as well as the prominent market drivers.


Some of the list of key market players:



  • Fujifilm Holdings Corporation

  • Samsung Electronics Co. Ltd

  • Ge Healthcare

  • Siemens Healthcare

  • Kohden Corporation

  • Koninklijke Philips NV


Recent Market Development:


Some of the major Asian regions want to give full efforts to improve their production work and meet the global challenge. Such economic regions also hold a huge number of potential to increase their manufacturing plants and factory production as one of the Ischemic Stroke market emerging player CERENOVUS has launched EMBOGUARD, which is a next generation balloon guide catheter that can be used in the endovascular procedures and such patients who are suffering from ischemic stroke problems.


Report Overview:


All the information about the ischemic stroke market and its symptoms to proper treatment are in this detailed report. Information about the key challenging fact that occurs during the global pandemic, and the companies that are mostly affected by the lockdown procedures are also available. The report offers complete details on the classification of global ischemic market sectors in the market segment section. All the reports provide complete and thorough info about the market's more prominent players and the investors.


Key Industrial Segment:


Diagnosis: 



  • Computed Tomography

  • Magnetic Resonance Imaging

  • Carotid Ultrasound

  • Cerebral Angiography

  • Electrocardiography

  • Echocardiography

  • Others


Drug Class:



  • Tissue Plasminogen Activator

  • Anticoagulant

  • Antiplatelet

  • Antihypertensive

  • Others


Surgery:



  • Carotid Endarterectomy

  • Angioplasty

  • Endovascular Mechanical Thrombectomy


End-User:



  • Hospitals & Clinic

  • Medical Institutes

  • Research Organization

  • Others


Regional Analysis:



  • Asia-pacific

  • Europe

  • North America

  • South America

  • Middle East & Africa



Report Scope:
Report Attribute/Metric Details
  Market Size   2030: Significant Value
  CAGR   8.50% (2020-2030)
  Base Year   2019
  Forecast Period   2020-2030
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Diagnosis, Drug Class, Surgery and End-Users
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Abbott Laboratories (U.S.), Medtronic plc (U.S.), Boston Scientific Corporation (U.S.), Cordis Corporation (U.S.), Koninklijke Philips N.V. (Netherland), GE Healthcare (U.S.), Stryker Corporation (U.S.), Genentech, Inc. (U.S.), Merck & Co., Inc. (U.S.), Bayer AG (Germany), Boehringer Ingelheim (Germany), Sanofi (France), Covidien plc (Ireland), Philips Healthcare (U.S.), Johnson & Johnson (U.S.), Penumbra, Inc. (U.S.), GE Healthcare (U.S.), Siemens Healthcare (U.S.), Hitachi, Ltd (Japan), Biogen (U.S.), Daiichi Sankyo (U.S.), Pfizer Inc. (U.S.), and others
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Rising cases of ischemia stroke
  • Increasing demand for minimally invasive procedures
  • Advancements in surgical procedures


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis.

    Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis.

    Ischemic stroke market is expected to grow at a CAGR of approximately 8.50% during the forecast period 2020-2030.

    Rising cases of ischemia stroke are driving the demand for surgical procedures in stroke treatment. Increasing demand for minimally invasive procedures and advancements in surgical procedures are the key factors boosting the growth of the global ischemic stroke market.

    The Americas has emerged as the largest market for the global ischemic stroke owing to the favorable government initiatives, technological innovations, and increasing demand for ischemic stroke products.

    Some of key the players in the ischemic stroke market are Abbott Laboratories (U.S.), Medtronic plc (U.S.), Boston Scientific Corporation (U.S.), Cordis Corporation (U.S.), Koninklijke Philips N.V. (Netherland), GE Healthcare (U.S.), Stryker Corporation (U.S.), Genentech, Inc. (U.S.), Merck & Co., Inc. (U.S.), Bayer AG (Germany), Boehringer Ingelheim (Germany), Sanofi (France), Covidien plc (Ireland), Philips Healthcare (U.S.), Johnson & Johnson (U.S.), Penumbra, Inc. (U.S.), GE Healthcare (U.S.), Siemens Healthcare (U.S.), Hitachi, Ltd (Japan), Biogen (U.S.), Daiichi Sankyo (U.S.), Pfizer Inc. (U.S.), and others